Professional Documents
Culture Documents
Measurements of flow and volume are most useful in the office setting.
Spirometry, which provides both these measures, requires neither
sophisticated technology nor expensive equipment, is easily interpreted,
and is reliable when performed correctly. A brief discussion of the
technique, clinical applications for and limitations of more sophisticated
measurements of lung volume, diffusion capacity, and respiratory muscle
function also is provided so that referrals for such testing can be made
appropriately.
Readers interested in a more comprehensive review of PFT in children are
referred elsewhere [2].
Interpretation of arterial blood gas analyses and exhaled nitric oxide,
exercise testing, assessment of bronchial hyperresponsiveness, sleep
studies, measurements of control of breathing, and PFT in adults are
discussed separately. (See "Oxygenation and mechanisms of
hypoxemia" and "Exhaled nitric oxide analysis and
applications" and "Overview of aerobic exercise testing in children and
adolescents" and "Bronchoprovocation testing" and "Evaluation of
suspected obstructive sleep apnea in children", section on
'Polysomnography' and"Control of ventilation" and "Overview of
pulmonary function testing in adults".)
SPIROMETRY
Overview Spirometry is the measurement of breathing over time. It
includes measures of flow and volume generated by a forced and
complete exhalation to residual volume (RV) after a full inspiration. The
volume-time curve graphic presentation (figure 1) has been largely
replaced in clinical practice by the flow-volume curve (figure 2 and figure
3), which provides a more immediate and intuitive perception of
obstructive and restrictive disorders. However, the two graphic depictions
are complementary and optimally should be analyzed together.
Spirometry also includes the measurement of flow and volume with
inspiration; however, inspiratory parameters are less commonly measured
and are not discussed here. (See "Flow-volume loops".)
Production of a reliable, sustained expiration requires coaching from the
clinician and both coordination and focus on the part of the subject. Thus,
spirometry is usually not obtainable predictably from children younger
than six years.
Spirometry is most useful for evaluation of common pediatric obstructive
lung diseases, such as asthma, cystic fibrosis (CF), and the sequelae of
bronchopulmonary dysplasia.
in each exhalate as it is "washed out" with the 100 percent oxygen being
inhaled. The volume of exhaled nitrogen is measured throughout the
procedure. FRC can be calculated by dividing the total volume of nitrogen
obtained by the difference in concentrations obtained.
Clinical application and interpretation
Restrictive disease Restrictive lung defects are defined by reduction
in functional lung volumes and can only be confirmed by such
measurements. In these conditions, the TLC is reduced to below 80
percent of that predicted by age, height, and gender. The RV remains
unchanged with hypotonia, or even increased in cases of chest wall
disease. Thus, the RV/TLC ratio is increased in children with these
disorders, which mainly affect inspiratory, or vital capacity (VC).
The most common pathologic conditions in which lung volume
determination is useful include:
Intrinsic lung diseases, such as interstitial pneumonias
Chest wall pathologies (eg, scoliosis)
Neuromuscular diseases (eg, Duchenne muscular dystrophy)
In restrictive defects caused by intrinsic pulmonary disease, the RV is
often reduced as well, resulting in a normal RV/TLC ratio. In restrictive lung
defects caused by neuromuscular weakness and chest and spine
deformities, the RV remains almost normal and the RV/TLC ratio is
increased (table 1).
Obstructive disease Lung volume measurements are not needed to
define obstructive defects, although such defects can lead to air trapping,
defined as an increased RV/TLC ratio in the setting of airway obstruction
(a reduced FEV1/FVC ratio). When air trapping is present, the TLC can be
normal or increased, the VC is normal or decreased, and the RV is
increased. The latter changes can be the earliest parameters detected in
early airway pathologies, such as cystic fibrosis (CF). Reduced
VC and/or symmetrically reduced VC and FEV1 should prompt lung volume
measurement.
DIFFUSION CAPACITY MEASUREMENT Diffusion capacity is typically
measured in specialized centers because of the cost and complexity of the
required equipment. The diffusing capacity of the lungs for carbon
monoxide (DLCO) and alveolar volume (VA) are measured in conditions in
which impairment of gas diffusion across the alveolar-capillary membrane
or a reduction in the alveolar-capillary surface area is suspected (eg, in